Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) may protect against vertebral fractures in people with diabetes, ...

A systematic review and meta-analysis evaluated the risk for obesity-related cancer associated with glucagon-like peptide-1 ...

It doesn't have the highest yield, but it has enviable dividend coverage and a long history of surviving in a competitive ...

GLP-1 RA therapy linked to significantly lower risk for epilepsy compared with DPP4-i use among adults with T2DM.

As physicians across specialties encounter increasing patient interest in GLP-1 receptor agonists, it is important for them ...

The use of GLP-1 drugs to treat obesity has cause awareness of the complex medical condition to surge. But the cost of ...

In today’s health headlines, can laughing gas help with depression? What to know about weight maintenance after stopping a ...

GreensKeeper Asset Management, an investment management company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here.

The ever-expanding popularity of GLP-1 drugs for weight loss is challenging employers to balance access and cost.

A viral Instagram video has sparked a fitness feud after one trainer hit back, calling another’s advice “a dangerous message.

Mondelez International, Inc. (NASDAQ:MDLZ) is among the consumer defensive stocks to buy according to analysts.

Wall Street was upbeat last week. The S&P 500 lost 0.6%, the Dow Jones advanced 1.1% and the Nasdaq retreated about 1.6% last week. The tech stocks were beaten down, taking a toll on the Nasdaq-100 as ...